Skip to main content
Log in

Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis

  • Experimental
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

The role of signal transducer and activator of transduction (STAT) 4 vs. 6 has been assessed thus far only in a model of high mortality strongly driven by proinflammation alone. Their role in a low-mortality (LD25) model of sepsis remains unclear.

Design and setting

Prospective controlled animal study in a research laboratory.

Subjects

STAT4 and STAT6 knockout mice.

Interventions

We induced sepsis by cecal ligation and puncture (CLP) or sham CLP in three groups of mice: (a) STAT4−/−, (b) STAT6−/−, (c) BALB/c. Splenic T cells or macrophages were then harvested 24 h after CLP, and their ability to produce cytokines was assessed.

Results

Following CLP T-cells from BALB/c mice were suppressed in the ability to release the Th1 cytokines interleukin (IL) 2 and interferon γ. The release of Th2 cytokine IL-10 was increased. The Th1 response of STAT4-deficient animals was not only markedly lower in shams but was further suppressed by CLP. The Th2 cytokine response was elevated even more than that of the septic BALB/c. This was associated with lower survival than in the BALB/c. STAT6 deficiency resulted in a stronger Th1 response and a suppressed Th2 response to CLP. A similar difference between IL-12 and IL-10 release was seen in macrophages from these mice. Interestingly, while this resulted in improved survival, compared to STAT4−/− mice, the STAT6−/− animals still had a higher mortality than the BALB/c.

Conclusions

These data suggest that contributions from both STAT4 driven processes as well as STAT6 responses are needed in a balanced fashion to maximize the animals’ ability to survive septic challenge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Mannick JA (1993) Trauma, sepsis and immune defects. In: Faist E, Meakins JL, Schildberg FW (eds) Host defense dysfunction in trauma, shock and sepsis.– Springer, Berlin Heidelberg New York, pp 15–21

  2. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH (1994) Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579–585

    Article  PubMed  Google Scholar 

  3. O’Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222:482–492

    PubMed  Google Scholar 

  4. DiPiro JT, Howdieshell TR, Goddard JK, Callaywa DB, Hamilton RG, Mansberger AR (1998) Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 130:1159–1163

    Google Scholar 

  5. Ferguson NR, Galley HF, Webster NR (1999) T helper subset ratios in patients with severe sepsis. Intensive Care Med 25:106–109

    Article  PubMed  Google Scholar 

  6. Stanilova SA, Karakolev ZT, Dimov GS, Dobreva ZG, Miteva LD, Slavov ES, Stefanov CS, Stanilov NS (2005) High interleukin 12 and low interleukin 10 production after in vitro stimulation detected in sepsis survivors. Intensive Care Med 31:401–407

    Article  PubMed  Google Scholar 

  7. Song GY, Chung CS, Chaudry IH, Ayala A (2000) IL-4-induced activation of the Stat6 pathway contributes to the suppression of cell-mediated immunity and death in sepsis. Surgery 128:133–138

    Article  PubMed  Google Scholar 

  8. Biron CA, Gazzinelli RT (1995) Effect of IL-12 on immune responses to microbial infections: a key mediator in regulating diseases outcome. Curr Opin Immunol 7:485–496

    Article  PubMed  Google Scholar 

  9. O’Suilleabhain C, O’Sullivan ST, Kelly JL, Lederer J, Mannick JA, Rodrick ML (1996) Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 120:290–296

    PubMed  Google Scholar 

  10. Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL (1999) Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 162:5437–5443

    PubMed  Google Scholar 

  11. Matsukawa A, Kaplan MH, Hogaboam CM, Lukacs NW, Kunkel SL (2001) Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med 193:679–688

    Article  PubMed  Google Scholar 

  12. Godshall CJ, Lentsch AB, Peyton JC, Scott MJ, Cheadle WG (2001) STAT4 is required for antibacterial defense but enhances mortality during polymicrobial sepsis. Clin Diagn Lab Immunol 8:1044–1048

    Article  PubMed  Google Scholar 

  13. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ (1990) Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602–3610

    PubMed  Google Scholar 

  14. Barriere SL, Lowry SF (1995) An overview of mortality risk prediction in sepsis. Crit Care Med 23:376–393

    Article  PubMed  Google Scholar 

  15. Abraham E (1999) Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med 25:556–566

    Article  PubMed  Google Scholar 

  16. Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 1998 9:1–11

    Google Scholar 

  17. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH (1992) Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophage to release inflammatory mediators (IL-1, IL-6 and TNF). Circ Shock 36:191–199

    PubMed  Google Scholar 

  18. Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in murine cecal ligation and puncture model. Surgery 94:331–335

    PubMed  Google Scholar 

  19. Meldrum DR, Ayala A, Perrin MM, Ertel W, Chaudry IH (1991) Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res 51:158–164

    Article  PubMed  Google Scholar 

  20. Ayala A, Lehman DL, Herdon CD, Chaudry IH (1994) Mechanism of enhanced susceptibility to sepsis following hemorrhage: interleukin (IL)-10 suppression of T-cell response is mediated by eicosanoid induced IL-4 release. Arch Surg 129:1172–1178

    PubMed  Google Scholar 

  21. Godshall CJ, Scott MJ, Peyton JC, Gardner SA, Cheadle WG (2002) Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 102:45–49

    Article  PubMed  Google Scholar 

  22. Song GY, Chung CS, Chaudry IH, Ayala A (1999) What is IL-10’s role in polymicrobial sepsis: anti-inflammatory agent or immune suppressant? Surgery 126:378–383

    Article  PubMed  Google Scholar 

  23. Lederer JA, Rodrick ML, Mannick JA (1999) The effects of injury on the adaptive immune response. Shock 11:153–159

    PubMed  Google Scholar 

  24. Ayala A, Chung CS, Song GY, Grutkoski PS, Simms HH (2003) Down-regulation of the immune response. In: Linden P, Doughty LA (eds) Molecular & cellular biology of critical care medicine.–. Kluwer, Norwell, pp 41–78

  25. Ayala A, Chung CS, Song GY (1999) Lymphocyte activation, anergy, and apoptosis in polymicrobial sepsis. In: Marshall JC, Cohen J (eds) Immune response in the critically ill– Springer, Berlin Heidelberg New York, pp 227–245

  26. Hotchkiss RS, Karl IE (2003) Medical progress: the pathophysiology and treatment of sepsis. N Engl J Med 348:138–150

    Article  PubMed  Google Scholar 

  27. Leonard WL, O’Shea JJ (1998) Jaks and Stats: biological implications. Annu Rev Immunol 16:293–322

    Article  PubMed  Google Scholar 

  28. Kaplan MH, Grusby MJ (1998) Regulation of T helper cell differentiation by STAT molecules. J Leukoc Biol 64:2–5

    PubMed  Google Scholar 

  29. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S (1996) Essential role of Stat6 in IL-4 signaling. Nature 380:627–630

    Article  PubMed  Google Scholar 

  30. Tong L, Pav S, White DM, Rogers S, Crane KM, Cywin CL, Brown ML, Pargellis CA (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat Struct Biol 4:311–318

    Google Scholar 

  31. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603–6610

    PubMed  Google Scholar 

  32. Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH (1997) Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 25:106–110

    Article  PubMed  Google Scholar 

  33. Zellweger R, Ayala A, Chaudry IH (1998) Predisposing factors: effects of sex, nutritional factors and age on immunity following shock and sepsis. In: Redl H, Schlag G (eds) Cytokines in severe sepsis and septic shock. Birkhauser, Basel, pp 57–77

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfred Ayala.

Additional information

This research was supported by grant R01 GM46354 (A.A.) from the National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, G.Y., Chung, CS., Rhee, R.J. et al. Loss of signal transducer and activator of transduction 4 or 6 signaling contributes to immune cell morbidity and mortality in sepsis. Intensive Care Med 31, 1564–1569 (2005). https://doi.org/10.1007/s00134-005-2793-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-005-2793-z

Keywords

Navigation